您的位置: 首页 > 农业专利 > 详情页

Botulinum toxin cell binding domain polypeptides and methods of use for treatments of fibrosis associated disorders
专利权人:
Inc.;Allergan
发明人:
JACKY, Birgitte PS,BRIDEAU-ANDERSEN, Amy,YOU, Hui,FRAIL, Donald E.,BRIN, Mitchell F.
申请号:
AU2018389121
公开号:
AU2018389121A1
申请日:
2018.12.20
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
A polypeptide having an amino acid sequence corresponding to a binding domain of a botulinum toxin is described. The polypeptide modulates expression of genes involved in, for example, collagen production and extra cellular matrix organization, and finds use, therefore in treating or reducing the occurrence of a disease such as a disease of the ECM, a connective or epithelial tissue disease, an endothelial disease or a fibrotic disease, e.g., a fibrotic disease of the ECM, connective tissue, or endothelium. Nucleic acids encoding the polypeptide, as well as vectors, host cells, and systems comprising the nucleic acids, are further described.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充